Atlas Trials

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Clinical trial NCT00663286 · COMPLETED

Trial details

NCT number
NCT00663286
Sponsor
Dow Pharmaceutical Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2006-10-01
Primary completion
2007-08-01
Enrollment
1399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.